SVEP1 is an Endogenous Ligand for the Orphan Receptor PEAR1
Overview
Authors
Affiliations
Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 (SVEP1) is an extracellular matrix protein that causally promotes vascular disease and associates with platelet reactivity in humans. Here, using a human genomic and proteomic approach, we identify a high affinity, disease-relevant, and potentially targetable interaction between SVEP1 and the orphan receptor Platelet and Endothelial Aggregation Receptor 1 (PEAR1). This interaction promotes PEAR1 phosphorylation and disease associated AKT/mTOR signaling in vascular cells and platelets. Mice lacking SVEP1 have reduced platelet activation, and exogenous SVEP1 induces PEAR1-dependent activation of platelets. SVEP1 and PEAR1 causally and concordantly relate to platelet phenotypes and cardiovascular disease in humans, as determined by Mendelian Randomization. Targeting this receptor-ligand interaction may be a viable therapeutic strategy to treat or prevent cardiovascular and thrombotic disease.
Clinical Insights from Proteomics in Heart Failure.
Lotfinaghsh A, Imam A, Pompian A, Stitziel N, Javaheri A Curr Heart Fail Rep. 2025; 22(1):12.
PMID: 40063168 DOI: 10.1007/s11897-025-00698-w.
Unconventional receptor functions and location-biased signaling of the lactate GPCR in the nucleus.
Mohammad Nezhady M, Cagnone G, Bajon E, Chaudhari P, Modaresinejad M, Hardy P Life Sci Alliance. 2025; 8(4).
PMID: 39904567 PMC: 11794946. DOI: 10.26508/lsa.202503226.
Maxwell C, Bhakta N, Denniff M, Sandhu J, Kessler T, Ng L J Mol Cell Cardiol Plus. 2025; 11:100283.
PMID: 39895831 PMC: 11782998. DOI: 10.1016/j.jmccpl.2025.100283.
Osawa I, Akita K, Hasegawa K, Fifer M, Tower-Rader A, Reilly M Circ Heart Fail. 2025; 18(2):e012343.
PMID: 39831317 PMC: 11835532. DOI: 10.1161/CIRCHEARTFAILURE.124.012343.
Sun Z, Harshfield E, de Leeuw F, Burgess S, Butterworth A, Riksen N Stroke. 2025; 56(3):692-704.
PMID: 39818967 PMC: 7617319. DOI: 10.1161/STROKEAHA.124.049079.